Dublin, April 17, 2020 (GLOBE NEWSWIRE) -- The "Nucleic Acid Based Gene Therapy Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering.

The global nucleic acid based gene therapy market was worth $557.47 million in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 10.00% and reach $816.18 million by 2023.

The nucleic acid-based gene therapy market covered in this report is segmented by technology into anti-sence and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers, others. It is also segmented by application into oncology, muscular dystrophy/ muscular disorders, rare diseases.

Nucleic Acid Based Gene Therapy Market Market Global Report 2020-30 from the author provides the strategists, marketers and senior management with the critical information they need to assess the global nucleic acid based gene therapy market market.

Reasons to Purchase

Where is the largest and fastest growing market for the nucleic acid based gene therapy market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Nucleic Acid Based Gene Therapy Market market global report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider nucleic acid based gene therapy market market, and compares it with other markets.

The nucleic acid-based gene therapy market consists of sales of nucleic acid-based gene therapy products and services. Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.

Rising financial support by the government and the companies is projected to drive the demand for nucleic acid based gene therapy. Nucleic acid therapeutics are analogs of naturally occurring acids or proteins responsible for genetic expression. The traditional therapies do not have any cure for the treatment of diseases such as cystic fibrosis, hemophilia, sickle cell anaemia, thalassemia, and diabetes. Genetic profiling and molecular target identification form the backbone of these classes of drugs. Nucleic acid medication has greater potential for the treatment of these diseases, as they target the genetic basis of diseases and have a permanent cure. Rising financial support by the government and the companies dealing in the market for gene therapy is expected to contribute to increasing the demand for nucleic acid-based gene therapies. For instance in October 2019, the USA National Institutes of Health (NIH) announced plans to invest $100 million for the next four years to cure HIV and sickle cell disease with gene therapies. The government support for gene therapies will contribute to the growth of the market.

Stringent regulations imposed on gene therapies raises the price of gene therapies, which in turn hinders the demand for nucleic acid-based gene therapies. The excessive regulatory oversights create an expensive and elongated route for approval increasing the expenses. According to Foundation for Economic Education (FEE), unlike other drugs approved or regulated by the Food and Drug Administration (FDA), gene therapies are not only subject to the regulatory structure of FDA, but also the Recombinant DNA Advisory Committee and Office of Biotechnology Activities. Also, as estimated by FEE, an approved gene therapy drug cost nearly $5.0 billion, which is five times higher than that of the average cost of FDA approval. The high cost of gene therapeutics drugs places them beyond the financial reach of the populace. This scenario is anticipated to restrain the market growth of the nucleic acid-based gene therapy market.

In May 2018, Vectalys, a leading biotechnology company specializing in the manufacturing of high-quality solutions for gene delivery and FlashCell, a company engaged in developing non-integrated lentiviral delivered RNA Therapeutics announced the merger to create Flash Therapeutics, a privately held gene therapy company developing cell and gene therapeutics. The new company Flash Therapeutics is expected to focus on the development of RNA therapeutics based on LentiFlash, a non-integrative lentiviral delivery technology for incurable diseases.

Major players in the market are Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN, BioMedica, Transgene and Copernicus Therapeutics.

Key Topics Covered:

1. Executive Summary

2. Nucleic Acid Based Gene Therapy Market Market Characteristics

3. Nucleic Acid Based Gene Therapy Market Market Size And Growth 3.1. Global Nucleic Acid Based Gene Therapy Market Historic Market, 2015 - 2019, $ Billion 3.1.1. Drivers Of The Market 3.1.2. Restraints On The Market 3.2. Global Nucleic Acid Based Gene Therapy Market Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion 3.2.1. Drivers Of The Market 3.2.2. Restraints On the Market

4. Nucleic Acid Based Gene Therapy Market Market Segmentation 4.1. Global Nucleic Acid Based Gene Therapy Market Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion4.2. Global Nucleic Acid Based Gene Therapy Market Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5. Nucleic Acid Based Gene Therapy Market Market Regional And Country Analysis 5.1. Global Nucleic Acid Based Gene Therapy Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion 5.2. Global Nucleic Acid Based Gene Therapy Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Nucleic Acid Based Gene Therapy Market Market

7. China Nucleic Acid Based Gene Therapy Market Market

8. India Nucleic Acid Based Gene Therapy Market Market

9. Japan Nucleic Acid Based Gene Therapy Market Market

10. Australia Nucleic Acid Based Gene Therapy Market Market

11. Indonesia Nucleic Acid Based Gene Therapy Market Market

12. South Korea Nucleic Acid Based Gene Therapy Market Market

13. Western Europe Nucleic Acid Based Gene Therapy Market Market

14. UK Nucleic Acid Based Gene Therapy Market Market

15. Germany Nucleic Acid Based Gene Therapy Market Market

16. France Nucleic Acid Based Gene Therapy Market Market

17. Eastern Europe Nucleic Acid Based Gene Therapy Market Market

18. Russia Nucleic Acid Based Gene Therapy Market Market

19. North America Nucleic Acid Based Gene Therapy Market Market

20. USA Nucleic Acid Based Gene Therapy Market Market

21. South America Nucleic Acid Based Gene Therapy Market Market

22. Brazil Nucleic Acid Based Gene Therapy Market Market

23. Middle East Nucleic Acid Based Gene Therapy Market Market

24. Africa Nucleic Acid Based Gene Therapy Market Market25. Nucleic Acid Based Gene Therapy Market Market Competitive Landscape And Company Profiles 25.1. Nucleic Acid Based Gene Therapy Market Market Competitive Landscape 25.2. Nucleic Acid Based Gene Therapy Market Market Company Profiles

26. Key Mergers And Acquisitions In The Nucleic Acid Based Gene Therapy Market Market

27. Nucleic Acid Based Gene Therapy Market Market Trends And Strategies

28. Nucleic Acid Based Gene Therapy Market Market Future Outlook and Potential Analysis

29. Appendix

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/k4398p

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

View original post here:
Global Nucleic Acid Based Gene Therapy Industry to 2030 - Featuring Celsion Corporation, Wave Life Sciences & Imugene Among Others - Yahoo Finance...

Comments are closed.